Wednesday, 19 Feb 2020

PsA/SpA

Date Typesort ascending Title Save
12 Nov 2019 Social RT @philipcrobinson: My write-up of data on IL-17 Inhibitors In Non-Radiographic Axial SpA presented here at #ACR19 @rheumnow https://t.co/…
17 Jun 2016 Social Swedish registries show (like RA) ankylosing spondylitis is assoc w/ 30%–50% increased risk of incident CV events. https://t.co/9B8CSxOEYi
24 Oct 2018 Social RT @ArthurRheum: Pooled analysis from 3 PSA+12 PSO trials on ixekizumab RCTs. Reassuring that incidence of IBD relatively low with signific…
11 Oct 2017 Social RT @DrAiLynTan: Important comorbidities to look out for & manage in #psoriatic arthritis via Dr Vinod Chandran #BSRaut17 #Leeds #medical #r…
02 Jun 2018 Social RheumNow Wk in Review is up. Good news for GPA and Renal transplant, Early RA challenges, Vaccinots and HPV and the risk of cancer in PsA. Check out the podcast https://t.co/nqif5yPBx9 or the website video https://t.co/bj6ar7ZlYT
14 Feb 2020 Social New GRAPPA treatment guidelines for psoriatic arthritis. Drs. Ruderman/Kavanaug #RWCS2020 @RWCSmtg https://t.co/uOsSabCzjB
12 Nov 2019 Social RT @uptoTate: The updated ACR/NPF treatment recommendations for PsA were discussed by Dr. Mease and Dr. E. Husni at #ACR19. Will you start…
24 Jun 2019 Social Study of PsA (N = 341) pts starting secukinumab with or without a baseline loading dose of SEC 150 mg, showed equal ACR20 responses at week 16 - 41.2% vs 39.8%. Despite some w/ an earlier response, the SEC loading dose may not be necessary. https://t.co/d3z9AQoeGM
18 Feb 2017 Social #rwcs2017 tofacitinib performs very well in refractory psoriatic arthritis, results from OPAL trial presented at A… https://t.co/MgsQpPdYU7
03 Dec 2018 Social Open source review Assessing Disease Activity in Psoriatic Arthritis: A Literature Review by Drs Tucker, Coates, Helliwell. How to assess arthritis, dactylitis, enthesitis, axial disease, skin & patient measures (PROMs). https://t.co/5SLwpeGbkn
19 Oct 2017 Social Dr Ian McInnes at #APLAR2017 shows decreasing responses with TNFi switching in PsA. https://t.co/ZSdslI9qld
15 Jun 2018 Social RT @PhilipGardiner: Question from the clinic: what can I give a patient with severe axSpA and Crohn’s resistant to multiple TNFis? Sekucinu…
16 Nov 2015 Social Dr Atul Deodhar on video at RheumNow, discussing new therapies for ankylosing splondylitis. Live from #ACR15 https://t.co/3kmXI0e1yu
13 Nov 2019 Social RT @Janetbirdope: 1/3 of pts using apremilast with PsA/SpA from Corrona data base are using it in combination with bDMARDs. Not sure how th…
07 Apr 2017 Social Dr. Ritchlin-30% psoriasis pts develop PsA, mechanisms unknown. enthesitis driven by biomechanical factors, arthritis involves IL-17, IL-23
15 Feb 2017 Social FDA approves the IL-17 Tx Siliq (brodalumab;Valeant) for mod-severe plaque psoriasis.Comes w/ black box for suicide https://t.co/rzSOVP1gd3
09 Nov 2017 Social @japaoli19 These are mostly of little or low evidence, are confusing and not prescriptive and without clear financ… https://t.co/7DG9AjQ9UH
13 Nov 2019 Social #ACR19 Rheumatology RoundUp - Kavanaughs Picks: 2505 PsA prevention 1366 Self Joint exams 1120 Rheum burnout 1310 OA Hx 565 Enteropathic arthritis Recs 1823 MRE dx of SI 2773 Machine learning 2772 Antiinflammatory diet in RA 1359 Synovial Bx
05 Nov 2017 Social Mease et al shows consentyx inhibits xray progression in Future5 996 PsA trial w 24wk outcomes https://t.co/qJqMZMulhP
26 Jun 2018 Social The risk of psoriatic arthritis in psoriasis is 23.8% according to a systematic review and metanalysis in JAAD (using CASPAR criteria). The incidence of PsA in psoriasis ranged from 0.27-2.7/100PY https://t.co/tnw41vFQe3